Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
ChromaDex revenue
ChromaDex's revenue is $72.1 million.
What is ChromaDex's revenue?
- ChromaDex's revenue growth from 2007 to 2022 is 1,415.54%.
- ChromaDex has 115 employees, and the revenue per employee ratio is $626,521.
- ChromaDex's peak quarterly revenue was $25.6M in 2024(q3).
- ChromaDex peak revenue was $72.0M in 2022.
- ChromaDex annual revenue for 2021 was 67.4M, 13.82% growth from 2020.
- ChromaDex annual revenue for 2022 was 72.0M, 6.82% growth from 2021.
On this page
Zippi applies for you, and finds you a job.
ChromaDex historical revenue
ChromaDex's peak revenue was $72.0M in 2022. The peak quarterly revenue was $25.6M in 2024(q3).
ChromaDex's revenue increased from $4.8m in 2007 to $72.0M currently. That's a 1,415.54% change in annual revenue.
ChromaDex annual revenue
ChromaDex annual revenue over time
| Fiscal year / year | ChromaDex revenue |
|---|---|
| 2009 | $5.8M |
| 2010 | $7.6M |
| 2011 | $8.1M |
| 2012 | $11.6M |
| 2013 | $10.2M |
| 2014 | $15.3M |
| 2015 | $17.9M |
| 2016 | $21.7M |
| 2017 | $21.2M |
| 2018 | $31.6M |
| 2019 | $46.3M |
| 2020 | $59.3M |
| 2021 | $67.4M |
| 2022 | $72.1M |
How accurately did ChromaDex's revenue projections match actual performance?
ChromaDex annual growth
ChromaDex saw the greatest revenue growth in 2014, when revenue increased by 50.71%.
ChromaDex had the lowest revenue growth in 2013, when revenue changed by -12.48%.
ChromaDex annual growth rate over time
| Year | ChromaDex growth |
|---|---|
| 2009 | 28%↑ |
| 2010 | 31%↑ |
| 2011 | 7%↑ |
| 2012 | 43%↑ |
| 2013 | -12%↓ |
| 2014 | 51%↑ |
| 2015 | 17%↑ |
| 2016 | 21%↑ |
| 2017 | -2%↓ |
| 2018 | 49%↑ |
| 2019 | 47%↑ |
| 2020 | 28%↑ |
| 2021 | 14%↑ |
| 2022 | 7%↑ |
ChromaDex jobs nearby
Do you work at ChromaDex?
Did ChromaDex meet its revenue projections?
ChromaDex financial information
| CEO | Robert N. Fried |
| Industry | Commercial & Professional Services |
| Company Type | Public |
| Employees Number | 115 |
| Date Founded | 1999 |
| Headquarters | Irvine, California |
| Number of Locations | 4 |
| Revenue | $72.1M |
| Net Income | -$16,540,000 |
| Gross Proft | $42.8M (2022) |
| PE Ratio | -11.23 |
| Tax Rate | 0.1% |
| Market Capitalization | $185.7M |
| Total Assets | $54,057,000 |
| Ticker | CDXC |
ChromaDex jobs you might like
ChromaDex financing
ChromaDex received early financing of $3.7M on 2010-05-27.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $3.7M | 05/2010 |
| Post Ipo Equity | $3.7M | 02/2012 |
| Post Ipo Equity | $3M | 10/2013 |
| Post Ipo Debt | $5M | 09/2014 |
| Post Ipo Equity | $750K | 12/2014 |
| Post Ipo Debt | $500K | 03/2016 |
| Post Ipo Equity | $5.1M | 08/2017 |
| Post Ipo Equity | $23.0M | 11/2017 |
| Post Ipo Equity | $7M | 08/2019 |
| Post Ipo Equity | $5M | 05/2020 |
| Post Ipo Equity | $25M | 02/2021 |
ChromaDex investors
| Investors | Security type |
|---|---|
| DSM | Post Ipo Equity |
| HERCULES CAPITAL INC | Post Ipo Debt |
ChromaDex competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Human Genome Sciences | $70,157 | $131.0M | 1,000 | - |
| Alnylam Pharmaceuticals | $81,014 | $2.2B | 1,323 | - |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 547 |
| GlobeImmune | $49,176 | $6.5M | 22 | - |
| Celera | $75,834 | - | 750 | - |
| Merck | $90,328 | $64.2B | 74,000 | 1,715 |
| New England Biolabs | $59,639 | $43.0M | 350 | - |
| Maxygen | $71,411 | $30.0M | 8 | - |
| Geron | $56,851 | $77.0M | 15 | - |
| Elysium Health | $50,306 | $5.0M | 45 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
ChromaDex highest paying jobs
Zippia gives an in-depth look into the details of ChromaDex, including salaries, political affiliations, employee data, and more, in order to inform job seekers about ChromaDex. The employee data is based on information from people who have self-reported their past or current employments at ChromaDex. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by ChromaDex. The data presented on this page does not represent the view of ChromaDex and its employees or that of Zippia.
ChromaDex may also be known as or be related to CHROMADEX CORP., ChromaDex, ChromaDex Corp., ChromaDex Corporation, ChromaDex Inc, ChromaDex, Inc. and Chromadex.